ANGLE PLC
Offers a liquid biopsy system to harvest circulating tumor cells for oncology diagnostics & research.
AGL | IL
Overview
Corporate Details
- ISIN(s):
- GB0034330679 (+3 more)
- LEI:
- 213800BY11K6W3NMS374
- Country:
- United Kingdom
- Address:
- GROUND FLOOR, 10 NUGENT ROAD, GU2 7AF GUILDFORD
- Website:
- https://angleplc.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
ANGLE plc is a medical diagnostics company specializing in liquid biopsy solutions for oncology. The company's core technology is the proprietary and patented Parsortix® system, which uses microfluidics to capture and harvest intact circulating tumor cells (CTCs) and CTC clusters from blood for downstream molecular analysis. ANGLE markets the FDA-cleared Parsortix PC1 instrument for use in clinical laboratories. Additionally, the company provides comprehensive, GCP-compliant laboratory services for biopharmaceutical and translational research clients, supporting projects in drug development and clinical studies. ANGLE's non-invasive technology enables detailed cancer analysis, aiming to improve diagnostics and patient care.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-05 19:30 |
Capital/Financing Update
Further Update on Funding
|
English | 10.6 KB | ||
| 2025-11-05 08:25 |
Regulatory News Service
CelLBxHealth Presents Proof-of-Concept Study
|
English | 16.9 KB | ||
| 2025-11-04 08:25 |
Regulatory News Service
Expert Consensus on CTCs; Update on Funding
|
English | 17.7 KB | ||
| 2025-10-29 08:00 |
Regulatory News Service
CHANGE OF NAME
|
English | 11.9 KB | ||
| 2025-10-16 08:00 |
Board/Management Information
Appointments: Interim CEO and senior board advisor
|
English | 14.9 KB | ||
| 2025-09-29 08:00 |
Regulatory News Service
Presentation of Data on Glioblastoma
|
English | 19.5 KB | ||
| 2025-09-09 08:01 |
Earnings Release
Interim Results
|
English | 255.8 KB | ||
| 2025-09-09 08:00 |
Board/Management Information
Change of Adviser
|
English | 12.5 KB | ||
| 2025-09-05 15:58 |
Report Publication Announcement
Notice of Results
|
English | 12.2 KB | ||
| 2025-08-20 08:00 |
Regulatory News Service
ANGLE announces collaboration with Myriad Genetics
|
English | 15.2 KB | ||
| 2025-06-30 18:50 |
Post-Annual General Meeting Information
Result of 2025 Annual General Meeting
|
English | 10.5 KB | ||
| 2025-06-06 08:00 |
Board/Management Information
Board Changes
|
English | 13.8 KB | ||
| 2025-05-28 08:00 |
Annual Report
Preliminary Results
|
English | 216.4 KB | ||
| 2025-05-23 08:00 |
Report Publication Announcement
Notice of Results
|
English | 12.2 KB | ||
| 2025-02-06 08:00 |
Regulatory News Service
Novel findings using Parsortix
|
English | 19.8 KB |
Automate Your Workflow. Get a real-time feed of all ANGLE PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ANGLE PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ANGLE PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
